Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board Medical Device Investing
Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor Life Science Investing
Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights Medical Device Investing
Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights Life Science Investing
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments Medical Device Investing
NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance Medical Device Investing
Republic Technologies Announces Revocation of FFCTO and Resumption of Trading Medical Device Investing
Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Pharmaceutical Investing
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates Medical Device Investing
Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston Medical Device Investing
